Tislelizumab,Sorafenib
BeiGene,bayer
['tislelizumab', 'beigene', '$bgne']
$bgne beigene announces data presentations at esmo 2022 including late-breaking oral presentation for tislelizumab in first-line unresectable hepatocellular cancer #cancer
¬ Retweeting Bloomberg's Feed all in one place.

¬ Market Updates

¬ I'm Barry Bloomberg putting out the fastest updates!

¬ Making your life easier.